Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

ReNeuron Group (RENE.L) settles Legal Dispute with Neuralstem (AMEX: CUR)

RENE.L  it has reached a settlement with CUR regarding the existing litigation in the US between the parties.

Under the terms of the settlement, ReNeuron makes no admission of liability and the lawsuit will be dismissed. The detailed financial terms are undisclosed.

  • The confidential settlement agreement resolves all claims asserted by CUR against RENE.L in Neuralstem, Inc. v. ReNeuron, Ltd., Case No# CV 08-02168, which was pending in the US District Court for the Central District of California.  

The Bottom Line: RENE.L will make future milestone and royalty payments to CUR tied to the successful development of stem cell products using certain of ReNeuron’s cell lines relevant to the case.